Axantia Is A Pharmaceutical Company Founded In 2014 Through A Joint Venture Involving The Abu Al Haj Familyal Faisaliah Groupand Sana Investment Groupbased In Ammanjordanwith Operations As A Dubai Based Holding Companyaxantia Specializes In Branded Generics And Under Licensed Pharmaceutical Productsthe Company Has A Presence In Over 20 Countries Across The Middle Eastafricaand The Cis Region Axantia Focuses On General Formulations And Cephalosporinsleveraging Over Two Decades Of Expertise In These Areasit Developsmanufacturesand Markets High Quality Branded Genericsprioritizing Affordability And Accessibilitythe Company Operates Two Manufacturing Sitesincluding Facilities In Saudi Arabiato Enhance Its Production Capabilitiesaxantia Serves Patientspayersand Caregivers Through Its Distribution Networktargeting Emerging Markets With A Commitment To Bio Pharmaceutical Innovationswith A Workforce Of 1 001 To 5 000 Employeesaxantia Emphasizes Regulatory Compliance And Actively Participates In Global Pharmaceutical Events
